Cargando…
Alterations of Plasma Galectin-3 and C3 Levels in Patients with Parkinson’s Disease
Parkinson’s disease (PD) is characterized by progressive neurodegeneration of dopaminergic neurons in the ventral midbrain. The complement-phagosome pathway is involved in the pathogenesis of PD. Here we measured levels of complement-phagocytosis molecules, including galectin-3, C3, C4, and cathepsi...
Autores principales: | Wu, Hsiu-Chuan, Chang, Kuo-Hsuan, Chiang, Mu-Chun, Chen, Chiung-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615685/ https://www.ncbi.nlm.nih.gov/pubmed/34827514 http://dx.doi.org/10.3390/brainsci11111515 |
Ejemplares similares
-
Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease
por: Chang, Kuo-Hsuan, et al.
Publicado: (2022) -
Association between CSF1 and CSF1R Polymorphisms and Parkinson’s Disease in Taiwan
por: Chang, Kuo-Hsuan, et al.
Publicado: (2019) -
Upregulation of APAF1 and CSF1R in Peripheral Blood Mononuclear Cells of Parkinson’s Disease
por: Chang, Kuo-Hsuan, et al.
Publicado: (2023) -
The Role of Oxidative Stress in Parkinson’s Disease
por: Chang, Kuo-Hsuan, et al.
Publicado: (2020) -
Biomarker of Neuroinflammation in Parkinson’s Disease
por: Liu, Tsai-Wei, et al.
Publicado: (2022)